Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project

Introduction Amidst growing consensus that stakeholder decision-making during drug development should be informed by an understanding of patient preferences, the Innovative Medicines Initiative project ‘Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle’ (PREFER) is developin...

Full description

Bibliographic Details
Main Authors: Matthias Englbrecht, Marie Falahee, Gwenda Simons, Rachael L DiSantostefano, Larissa Valor Méndez, Christine Radawski, Karin Schölin Bywall, Stephanie Tcherny-Lessenot, Ulrik Kihlbom, Brett Hauber, Jorien Veldwijk
Format: Article
Language:English
Published: BMJ Publishing Group 2021-04-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/4/e045851.full